AV-1 (AbViro)

N/A

Report date: 2025/02/27 20:00:09

Base Information

Drug NameAV-1 (AbViro)
Drug Alias NameAV-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbviro Llc
China Registration ClassN/A

Develop Information

Active CompaniesAbviro Llc
Inactive CompaniesN/A
Active IndicationsDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A